Apogee Therapeutics, Inc. · NASDAQ:APGE
T. Rowe Price Investment Management, Inc.'s stake in Apogee Therapeutics, Inc. fell to 1.30% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 8, 2026
T. Rowe Price Investment Management, Inc.'s stake in Apogee Therapeutics, Inc. fell to 1.30%, 772,969 shares, as a passive investor on Jun 30, 2026. Filed Jul 8, 2026 (Schedule 13G/A).
- Stake
- 1.30%
- Shares
- 772,969
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 1.30% | 772,969 |
Source
Related
- Apogee Therapeutics, Inc.
- T. Rowe Price Investment Management, Inc.
- Apogee Therapeutics, Inc. shareholders
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Apr 8, 2026
- Schedule 13G · T. Rowe Price Investment Management, Inc. · Mar 6, 2026
- Schedule 13D/A · Venrock Healthcare Capital Partners III, L.P. · Sep 8, 2026
- Form 4 · Fairmount Funds Management LLC · Sep 3, 2026
- Form 4 · McKenna Mark C. · Sep 3, 2026
- Form 4 · Jones William A Jr · Sep 3, 2026
- Form 4 · Dambkowski Carl · Sep 3, 2026